Skip to main content

Abstract

Cardiac surgery with exposure to an extracorporeal circuit is associated with fibrinolysis. Fibrinolysis results in coagulation factor consumption and an increased risk of bleeding. Antifibrinolytics like tranexamic acid, aprotinin, and ε-aminocaproic acid are therefore administered in a prophylactic fashion with a high level of evidence for the prevention of bleeding and blood transfusions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G, Surgical, Clinical Outcome Research Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96:478–85.

    Article  Google Scholar 

  2. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;91:1122–51.

    Article  CAS  Google Scholar 

  3. Bouma BN, Marx PF, Mosnier LO, Meijers JC. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Thromb Res. 2001;101:329–54.

    Article  CAS  Google Scholar 

  4. Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem. 2004;279:18434–9.

    Article  CAS  Google Scholar 

  5. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356:2301–11.

    Article  CAS  Google Scholar 

  6. Levy JH. Antifibrinolytic therapy: new data and new concepts. Lancet. 2010;376:3–4.

    Article  Google Scholar 

  7. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion. Cochrane Database Syst Rev. 2007;1:CD001886.

    Google Scholar 

  8. Mangano DT, Tudor IC, Dietzel C, Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353–65.

    Article  CAS  Google Scholar 

  9. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46:327–38.

    Article  CAS  Google Scholar 

  10. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–31.

    Article  CAS  Google Scholar 

  11. European Society of Anaesthesiology Task Force Reports on Place of Aprotinin in Clinical Anaesthesia. Aprotinin: is it time to reconsider? Eur J Anaesthesiol. 2015;32:591–5.

    Article  Google Scholar 

  12. Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136–48.

    Article  CAS  Google Scholar 

  13. Koster A, Faraoni D, Levy JH. Antifibrinolytic therapy for cardiac surgery: an update. Anesthesiology. 2015;123:214–21.

    Article  CAS  Google Scholar 

  14. Kratzer S, Irl H, Mattusch C, et al. Tranexamic acid impairs gamma-aminobutyric acid receptor type A-mediated synaptic transmission in the murine amygdala: a potential mechanism for drug-induced seizures? Anesthesiology. 2014;120:639–49.

    Article  CAS  Google Scholar 

  15. Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012;122:4654–66.

    Article  CAS  Google Scholar 

  16. Jerath A, Yang QJ, Pang KS, et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg. 2018;127:1323–32.

    Article  CAS  Google Scholar 

  17. Sigaut S, Tremey B, Ouattara A, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2014;120:590–600.

    Article  CAS  Google Scholar 

  18. Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2017;25:1–34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Faraoni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Faraoni, D. (2019). Fibrinolysis. In: von Heymann, C., Boer, C. (eds) Patient Blood Management in Cardiac Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-15342-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15342-7_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15341-0

  • Online ISBN: 978-3-030-15342-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics